| Literature DB >> 16111488 |
Abstract
BACKGROUND: Phosphorylation is a reversible post-translational modification that affects the intrinsic properties of proteins, such as structure and function. Non-synonymous single nucleotide polymorphisms (nsSNPs) result in the substitution of the encoded amino acids and thus are likely to alter the phosphorylation motifs in the proteins.Entities:
Mesh:
Year: 2005 PMID: 16111488 PMCID: PMC1208866 DOI: 10.1186/1471-2407-5-107
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
nsSNPs that abolish or create putative phosphorylated residues in DNA repair and cell cycle proteins. Only the NetPhos [22] predictions that remove or create a site at either the SNP location or at kinase recognition motifs are shown. The nsSNPs that create or abolish putative phosphorylation sites at the nsSNP position are shown in bold. Under the wild type and variant columns are the NetPhos outputs with the location of the amino acid, the phosphorylation motif (the putative phosphorylated residue is underlined), the score, and the residue being phosphorylated. 1 and 2 under the frequency column represents the nsSNP minor allele frequencies <5% and ≥5%, respectively [20-21]. Please note that the BRCA1 and NFKB1 proteins were initially identified as cell cycle protein interacting proteins [21]. However, in this manuscript, we classified the BRCA1 as a DNA repair and the NFKB1 as a cell cycle protein. §The putative phosphorylation sites that are also predicted in mouse proteins.
| BRCA1 | NM_007294.1 | SNP000007492 | P871L | 2 | 868 SKRQ | - | |
| BRCA1 | NM_007294.1 | rs4986852 | S1040N | 1 | §1041 KEAS | - | |
| ERCC2 | NM_000400.1 | SNP000000054 | H201Y | 1 | - | ||
| ERCC4 | NM_005236.1 | SNP000000067 | P379S | 1 and 2 | - | ||
| ERCC5 | NM_000123.1 | SNP001026027 | S311C | 1 | - | ||
| IGHMBP2 | NM_002180.1 | SNP000012785 | T671A | 2 | §672 GPAT | - | |
| LIG4 | NM_002312.2 | rs3093765 | P231S | 1 | - | ||
| OGG1 | NM_002542.4 | SNP000064679 | S326C | 2 | - | ||
| WRN | NM_000553.2 | SNP001026663 | S1079L | 1 | a) §1083 SKTV | - | |
| XRCC1 | NM_006297.1 | SNP000064196 | P309S | 1 | - | ||
| XRCC3 | NM_005432.2 | SNP000000060 | T241M | 2 | § | - | |
| CCND3 | NM_001760.2 | rs1051130 | S259A | 2 | - | ||
| CCNI | NM_006835.2 | rs4252903 | V207I | 1 | §208 LAMV | - | |
| CDKN1A | NM_000389.2 | SNP000003435 | S31R | 2 | - | ||
| NFKB1 | NM_003998.2 | rs4648099 | H712Q | 1 | 716 HVDS | - |
Distribution of the nsSNPs predicted to alter the phosphorylation sites.
| Abolished ≥1 putative phosphorylated residue (S, T or Y) at the nsSNP location | 3 | 2 | 5 |
| Abolished ≥1 putative phosphorylated residue by changing the kinase recognition motif | 5 | 2 | 7 |
| Created ≥1 putative phosphorylated residue (S, T or Y) at the nsSNP location | 4 | 0 | 4 |
| Created ≥1 putative phosphorylated residue by changing the kinase recognition motif | 0 | 0 | 0 |
Common nsSNPs with a possible role in cancer predisposition. Only the information derived from the studies on the protein function as well as the studies with a suggestion of disease-association have been included. 1 and 2 under the frequency column represents the nsSNP with minor allele frequencies <5% and ≥5%, respectively [20-21].
| BRCA1 | P871L | Abolishes at S869 | 2 | - | - | |
| ERCC4 | P379S | Creates at S379 | 1 and 2 | - | - | |
| IGHMBP2 | T671A | Abolishes at S672 | 2 | - | - | |
| OGG1 | S326C | Abolishes at S326 | 2 | Yamane | Sugimura | |
| XRCC3 | T241M | Abolishes and T241 | 2 | Yoshihara | Winsey | |
| CCND3 | S259A | Abolishes at S359 | 2 | - | - | |
| CDKN1A | S31R | Abolishes at S31 | 2 | Chedid | Wu |